Cite
A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate
MLA
Jean-Claude Carel, et al. “A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 Mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.” Hormone Research in Paediatrics, vol. 86, no. 3, Mar. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....727093f3956d04480cdeaf75a48199b7&authtype=sso&custid=ns315887.
APA
Jean-Claude Carel, Co-Investigators, Nilani Liyanage, Najiba Lahlou, Evelyne Jacqz-Aigrain, Joëlle Blumberg, & Delphine Zenaty. (2016). A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate. Hormone Research in Paediatrics, 86(3).
Chicago
Jean-Claude Carel, Co-Investigators, Nilani Liyanage, Najiba Lahlou, Evelyne Jacqz-Aigrain, Joëlle Blumberg, and Delphine Zenaty. 2016. “A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 Mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate.” Hormone Research in Paediatrics 86 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....727093f3956d04480cdeaf75a48199b7&authtype=sso&custid=ns315887.